TRT for men: what the science says vs. what TikTok sells

What's this video probably claiming?

A TikTok explaining how testosterone replacement therapy works for men is almost certainly covering the basics: low testosterone causes fatigue, low libido, and muscle loss, and injecting or applying exogenous testosterone fixes all of that. Creators in this space tend to frame TRT as a straightforward solution, walking viewers through delivery methods like cypionate injections, topical gels, or subcutaneous pellets. The framing is usually optimistic. Expect language about "optimization," energy restoration, and body composition changes. What you probably won't get is a clear explanation of who actually qualifies for TRT under clinical guidelines, what the diagnostic threshold for hypogonadism actually is, or what happens to your own testosterone production once you start. That nuance rarely survives the 60-second format.

What does the science actually show?

The clinical evidence for TRT in men with confirmed hypogonadism, defined by the Endocrine Society as two morning total testosterone levels below 300 ng/dL plus symptoms, is genuinely solid. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies published in NEJM and JAMA between 2016 and 2017, showed statistically significant improvements in sexual function, bone density, and anemia in hypogonadal men aged 65 and older. Effect sizes on mood and energy were more modest than TikTok would have you believe. Bhasin et al. (2018, NEJM) reported that 125 mg/week testosterone enanthate produced meaningful gains in muscle strength and mass in dose-response fashion, but those were supraphysiologic doses. For men in the normal range who just feel tired, the evidence that TRT helps is thin.

Where does the social media noise diverge from clinical reality?

The biggest distortion is the conflation of hypogonadism treatment with general male "optimization." Clinically, TRT is indicated for a specific pathological condition. On TikTok, it gets sold as a performance upgrade for men in their 30s with low-normal testosterone, sometimes called "functional" hypogonadism, which is not a recognized diagnostic category in the Endocrine Society or AUA guidelines. The second distortion is around side effects. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing intratesticular testosterone and causing azoospermia in a meaningful percentage of users. Masarani et al. (2006, Journal of Family Planning and Reproductive Health Care) documented that testosterone-induced infertility can persist months to years after discontinuation. Hematocrit elevation and cardiovascular risk are also real concerns that rarely make it into the caption.

What should you actually know?

If you're considering TRT, the diagnostic workup matters as much as the treatment itself. You need at least two early-morning total testosterone measurements, ideally with free testosterone, LH, and FSH, to distinguish primary from secondary hypogonadism. The cutoff is not 400, 500, or whatever number you read on a forum. Pellet implants, while popular on social media, have the least flexible dosing and the highest reported infection rates among delivery methods, per a 2019 review by Khera et al. in Sexual Medicine Reviews. Gels carry a real transference risk to partners and children. Cypionate and enanthate injections remain the most evidence-backed options for titration. And if fertility matters to you, you need that conversation before you start, not after your sperm count drops.